Skip to content

Sunshine Biopharma Inc.

SBFM· NasdaqCore metricsCIK 1402328

Pharmaceutical preparations553 peers

Last sale
Nov 12, 2026 · +5.19%
Market cap
$2.42M
823.77K shares
Filings
432
$9.44M
Q3 2026+4.1% FY25 yoy
-$1.22M
Q3 2026N/M FY25 yoy
-$1.29M
Q3 2026N/M FY25 yoy
-$3.00M
Q2 2026derivedN/M FY25 yoy
-$0.98
Q3 2025N/M FY24 yoy
$14.62M
Q3 2026−5.8% FY25 yoy
$2.42M
—
0.1×
0.1×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$2.94+69.94%+$1.21past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$36.31MFY 2025
$36.31M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$36,305,891reported
FY 20242024-12-31$34,874,283reported
FY 20232023-12-31$24,092,787reported
FY 20222022-12-31$4,345,603reported
FY 20212021-12-31$228,426reported
FY 20202020-12-31$71,410reported
FY 20192019-12-31$21,121reported
FY 20182018-12-31$0 revisedreported
FY 20172017-12-31$0reported
FY 20162016-12-31$0reported
FY 20152015-12-31$1,708reported
FY 20142014-12-31$0reported

Capital returns

Dividends and buybacks · FY2023 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$0.00$0.00—4.91M sh+81.2%—
FY2024—$3.14M$3.14M—2.71M sh−97.3%—
FY2023—$541.14K$541.14K—99.45M sh+340.3%—

Pharmaceutical preparations

Sunshine Biopharma Inc. is the 140th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR